Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2253649 | 0.81 | LMNA (0.64) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL3992905 | 0.80 | MEN1 (0.50) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL27879907 | 0.78 | KMT2A (0.48) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL2122417 | 0.78 | MEN1 (0.48) | TSHRMEN1KMT2AALDH1A1MAPT | |
| Ethyl Benzoate SCHEMBL25388294 | 0.76 | LMNA (0.70) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL11494915 | 0.76 | MEN1 (0.47) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL1641519 | 0.76 | ALDH1A1 (0.47) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL7675831 | 0.76 | KMT2A (0.47) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL9041640 | 0.76 | ALDH1A1 (0.47) | TSHRMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL2117571 | 0.76 | MEN1 (0.47) | TSHRMEN1KMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3575281-B1 | DIAMINE COMPOUND, AND POLYIMIDE COMPOUND AND MOLDED ARTICLE IN WHICH SAID DIAMINE COMPOUND IS USED | WINGO TECH CO LTD (JP) | 2023-08-23 | — | — | EP | claimed |
| CN-101434572-B | Prodrugs of GABA analogs, compositions and uses thereof | XENOPORT INC | 2013-03-13 | — | — | CN | claimed |
| EP-2363390-A1 | DERIVED LACTAM FROM D3 VITAMIN | Teijin Pharma Limited (JP) | 2011-09-07 | — | — | EP | claimed |
| US-20110207944-A1 | VITAMIN D3 LACTAM DERIVATIVE | TEIJIN PHARMA LIMITED (JP) | 2011-08-25 | — | — | US | claimed |
| CN-101381339-A | Prodrugs of gaba analogs, compositions and uses thereof | XENOPORT INC (US) | 2009-03-11 | — | — | CN | claimed |
| CN-1753673-A | Prodrugs of gaba analogs, compositions and uses thereof | XENOPORT INC (US) | 2006-03-29 | — | — | CN | claimed |
| CN-118176259-A | Dispersion of carbon nanotubes, coating liquid composition for electrode using same, electrode, and lithium ion secondary battery | 第一工业制药株式会社 | 2024-06-11 | — | — | CN | disclosed |
| CN-117866200-A | Polybenzoxazole precursor, process for producing the same, and photosensitive resin composition | 上海交通大学 | 2024-04-12 | — | — | CN | disclosed |
| EP-3575281-B1 | DIAMINE COMPOUND, AND POLYIMIDE COMPOUND AND MOLDED ARTICLE IN WHICH SAID DIAMINE COMPOUND IS USED | WINGO TECH CO LTD (JP) | 2023-08-23 | — | — | EP | disclosed |
| CN-113518792-B | Polybenzoxazole precursor containing ester diamine, photosensitive resin composition, dry film, cured product, and electronic component | 太阳控股株式会社 | 2023-08-15 | — | — | CN | disclosed |
| WO-2023080059-A1 | DISPERSION OF CARBON NANOTUBES, COATING LIQUID COMPOSITION FOR ELECTRODE USING SAME, ELECTRODE, AND LITHIUM ION SECONDARY BATTERY | 第一工業製薬株式会社 | 2023-05-11 | — | — | WO | disclosed |
| CN-111770951-B | Polyimide compound and molded article comprising same | 胜高科技股份有限公司 | 2023-04-11 | — | — | CN | disclosed |
| US-20220162445-A1 | POLYIMIDE COMPOUND AND MOLDED ARTICLE COMPRISING THE POLYIMIDE COMPOUND | WINGO TECHNOLOGY CO., LTD. (JP) | 2022-05-26 | — | — | US | disclosed |
| US-5082943-A | Antiulcer | NIPPON CHEMIPHAR CO., LTD. (JP) | 1992-01-21 | — | — | US | disclosed |
| EP-0382185-A2 | Carbostyril derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-08-16 | — | — | EP | disclosed |
| EP-0354788-A1 | Novel imidazole derivatives | NIPPON CHEMIPHAR CO., LTD. (JP) | 1990-02-14 | — | — | EP | disclosed |
| US-4727073-A | CEREBOVASCULAR DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-02-23 | — | — | US | disclosed |
| US-4678792-A | ANTITHROMBIC AGENTS | DR. KARL THOMAE GMBH (DE) | 1987-07-07 | — | — | US | disclosed |
| EP-0223245-A2 | Curable compositions for dental drugs having sustained release property | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1987-05-27 | — | — | EP | disclosed |
| EP-0177287-A2 | Pyrimidine derivatives, processes for preparation thereof and composition of the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207944-A1 | VITAMIN D3 LACTAM DERIVATIVE | VDR, CYP24A1, CYP2R1 | TSHR 1981/4885MEN1 290/4885KMT2A 3742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.